nodes	percent_of_prediction	percent_of_DWPC	metapath
Amobarbital—CYP2A6—prostate cancer	0.633	1	CbGaD
Amobarbital—Body temperature increased—Cabazitaxel—prostate cancer	0.000909	0.00421	CcSEcCtD
Amobarbital—Dizziness—Nilutamide—prostate cancer	0.000904	0.00418	CcSEcCtD
Amobarbital—Dizziness—Flutamide—prostate cancer	0.0009	0.00416	CcSEcCtD
Amobarbital—Hypersensitivity—Degarelix—prostate cancer	0.000899	0.00416	CcSEcCtD
Amobarbital—Somnolence—Bicalutamide—prostate cancer	0.000877	0.00406	CcSEcCtD
Amobarbital—Nausea—Estrone—prostate cancer	0.000874	0.00404	CcSEcCtD
Amobarbital—Vomiting—Nilutamide—prostate cancer	0.000869	0.00402	CcSEcCtD
Amobarbital—Anxiety—Ethinyl Estradiol—prostate cancer	0.000867	0.00401	CcSEcCtD
Amobarbital—Vomiting—Flutamide—prostate cancer	0.000865	0.004	CcSEcCtD
Amobarbital—Rash—Nilutamide—prostate cancer	0.000862	0.00399	CcSEcCtD
Amobarbital—Dermatitis—Nilutamide—prostate cancer	0.000861	0.00398	CcSEcCtD
Amobarbital—Rash—Flutamide—prostate cancer	0.000858	0.00397	CcSEcCtD
Amobarbital—Dermatitis—Flutamide—prostate cancer	0.000857	0.00397	CcSEcCtD
Amobarbital—Headache—Nilutamide—prostate cancer	0.000856	0.00396	CcSEcCtD
Amobarbital—Headache—Flutamide—prostate cancer	0.000852	0.00394	CcSEcCtD
Amobarbital—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000849	0.00393	CcSEcCtD
Amobarbital—Hypersensitivity—Cabazitaxel—prostate cancer	0.000847	0.00392	CcSEcCtD
Amobarbital—Constipation—Bicalutamide—prostate cancer	0.000843	0.0039	CcSEcCtD
Amobarbital—Mental disability—Capecitabine—prostate cancer	0.000825	0.00382	CcSEcCtD
Amobarbital—Tension—Goserelin—prostate cancer	0.000825	0.00382	CcSEcCtD
Amobarbital—Tension—Conjugated Estrogens—prostate cancer	0.000817	0.00378	CcSEcCtD
Amobarbital—Nervousness—Goserelin—prostate cancer	0.000817	0.00378	CcSEcCtD
Amobarbital—Vomiting—Estradiol valerate/Dienogest—prostate cancer	0.000816	0.00378	CcSEcCtD
Amobarbital—Feeling abnormal—Bicalutamide—prostate cancer	0.000813	0.00376	CcSEcCtD
Amobarbital—Nausea—Nilutamide—prostate cancer	0.000812	0.00376	CcSEcCtD
Amobarbital—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000809	0.00375	CcSEcCtD
Amobarbital—Nervousness—Conjugated Estrogens—prostate cancer	0.000809	0.00374	CcSEcCtD
Amobarbital—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000809	0.00374	CcSEcCtD
Amobarbital—Nausea—Flutamide—prostate cancer	0.000808	0.00374	CcSEcCtD
Amobarbital—Dizziness—Degarelix—prostate cancer	0.000807	0.00374	CcSEcCtD
Amobarbital—Headache—Estradiol valerate/Dienogest—prostate cancer	0.000804	0.00372	CcSEcCtD
Amobarbital—Liver injury—Epirubicin—prostate cancer	0.000787	0.00364	CcSEcCtD
Amobarbital—Body temperature increased—Bicalutamide—prostate cancer	0.00078	0.00361	CcSEcCtD
Amobarbital—Vomiting—Degarelix—prostate cancer	0.000776	0.00359	CcSEcCtD
Amobarbital—Rash—Degarelix—prostate cancer	0.00077	0.00356	CcSEcCtD
Amobarbital—Dermatitis—Degarelix—prostate cancer	0.000769	0.00356	CcSEcCtD
Amobarbital—Headache—Degarelix—prostate cancer	0.000765	0.00354	CcSEcCtD
Amobarbital—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.000763	0.00353	CcSEcCtD
Amobarbital—Angioedema—Conjugated Estrogens—prostate cancer	0.000761	0.00352	CcSEcCtD
Amobarbital—Dizziness—Cabazitaxel—prostate cancer	0.00076	0.00352	CcSEcCtD
Amobarbital—Syncope—Conjugated Estrogens—prostate cancer	0.000747	0.00346	CcSEcCtD
Amobarbital—Hyperkinesia—Prednisone—prostate cancer	0.000739	0.00342	CcSEcCtD
Amobarbital—Loss of consciousness—Conjugated Estrogens—prostate cancer	0.000732	0.00339	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Capecitabine—prostate cancer	0.000731	0.00339	CcSEcCtD
Amobarbital—Vomiting—Cabazitaxel—prostate cancer	0.000731	0.00338	CcSEcCtD
Amobarbital—Liver injury—Doxorubicin—prostate cancer	0.000728	0.00337	CcSEcCtD
Amobarbital—Hypersensitivity—Bicalutamide—prostate cancer	0.000727	0.00336	CcSEcCtD
Amobarbital—Bradycardia—Mitoxantrone—prostate cancer	0.000726	0.00336	CcSEcCtD
Amobarbital—Nausea—Degarelix—prostate cancer	0.000725	0.00336	CcSEcCtD
Amobarbital—Thinking abnormal—Epirubicin—prostate cancer	0.000724	0.00335	CcSEcCtD
Amobarbital—Headache—Cabazitaxel—prostate cancer	0.00072	0.00333	CcSEcCtD
Amobarbital—Anxiety—Goserelin—prostate cancer	0.000713	0.0033	CcSEcCtD
Amobarbital—Constipation—Ethinyl Estradiol—prostate cancer	0.000713	0.0033	CcSEcCtD
Amobarbital—Anxiety—Conjugated Estrogens—prostate cancer	0.000707	0.00327	CcSEcCtD
Amobarbital—Phenobarbital—CYP2C18—prostate cancer	0.000706	0.129	CrCbGaD
Amobarbital—Confusional state—Goserelin—prostate cancer	0.000692	0.0032	CcSEcCtD
Amobarbital—Feeling abnormal—Ethinyl Estradiol—prostate cancer	0.000687	0.00318	CcSEcCtD
Amobarbital—Nausea—Cabazitaxel—prostate cancer	0.000683	0.00316	CcSEcCtD
Amobarbital—Shock—Goserelin—prostate cancer	0.000675	0.00313	CcSEcCtD
Amobarbital—Ataxia—Docetaxel—prostate cancer	0.00067	0.0031	CcSEcCtD
Amobarbital—Thinking abnormal—Doxorubicin—prostate cancer	0.000669	0.0031	CcSEcCtD
Amobarbital—Shock—Conjugated Estrogens—prostate cancer	0.000669	0.0031	CcSEcCtD
Amobarbital—Hepatocellular injury—Epirubicin—prostate cancer	0.000662	0.00307	CcSEcCtD
Amobarbital—Body temperature increased—Ethinyl Estradiol—prostate cancer	0.000659	0.00305	CcSEcCtD
Amobarbital—Injection site reaction—Epirubicin—prostate cancer	0.000658	0.00305	CcSEcCtD
Amobarbital—Tension—Estradiol—prostate cancer	0.000654	0.00303	CcSEcCtD
Amobarbital—Dizziness—Bicalutamide—prostate cancer	0.000652	0.00302	CcSEcCtD
Amobarbital—Ataxia—Capecitabine—prostate cancer	0.000649	0.003	CcSEcCtD
Amobarbital—Nervousness—Estradiol—prostate cancer	0.000647	0.003	CcSEcCtD
Amobarbital—Hypotension—Goserelin—prostate cancer	0.000641	0.00297	CcSEcCtD
Amobarbital—Hypotension—Conjugated Estrogens—prostate cancer	0.000635	0.00294	CcSEcCtD
Amobarbital—Vomiting—Bicalutamide—prostate cancer	0.000627	0.0029	CcSEcCtD
Amobarbital—Rash—Bicalutamide—prostate cancer	0.000622	0.00288	CcSEcCtD
Amobarbital—Dermatitis—Bicalutamide—prostate cancer	0.000621	0.00288	CcSEcCtD
Amobarbital—Headache—Bicalutamide—prostate cancer	0.000618	0.00286	CcSEcCtD
Amobarbital—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000614	0.00284	CcSEcCtD
Amobarbital—Hepatocellular injury—Doxorubicin—prostate cancer	0.000613	0.00284	CcSEcCtD
Amobarbital—Agitation—Estradiol—prostate cancer	0.000612	0.00284	CcSEcCtD
Amobarbital—Somnolence—Goserelin—prostate cancer	0.00061	0.00282	CcSEcCtD
Amobarbital—Injection site reaction—Doxorubicin—prostate cancer	0.000609	0.00282	CcSEcCtD
Amobarbital—Angioedema—Estradiol—prostate cancer	0.000609	0.00282	CcSEcCtD
Amobarbital—Somnolence—Conjugated Estrogens—prostate cancer	0.000604	0.0028	CcSEcCtD
Amobarbital—Pentobarbital—CYP2A6—prostate cancer	0.000601	0.109	CrCbGaD
Amobarbital—Syncope—Estradiol—prostate cancer	0.000598	0.00277	CcSEcCtD
Amobarbital—Constipation—Goserelin—prostate cancer	0.000587	0.00272	CcSEcCtD
Amobarbital—Nausea—Bicalutamide—prostate cancer	0.000586	0.00271	CcSEcCtD
Amobarbital—Loss of consciousness—Estradiol—prostate cancer	0.000586	0.00271	CcSEcCtD
Amobarbital—Phenobarbital—CYP1B1—prostate cancer	0.000584	0.106	CrCbGaD
Amobarbital—Constipation—Conjugated Estrogens—prostate cancer	0.000581	0.00269	CcSEcCtD
Amobarbital—Mental disability—Epirubicin—prostate cancer	0.000575	0.00266	CcSEcCtD
Amobarbital—Anxiety—Estradiol—prostate cancer	0.000565	0.00262	CcSEcCtD
Amobarbital—Feeling abnormal—Goserelin—prostate cancer	0.000565	0.00262	CcSEcCtD
Amobarbital—Dizziness—Ethinyl Estradiol—prostate cancer	0.000551	0.00255	CcSEcCtD
Amobarbital—Confusional state—Estradiol—prostate cancer	0.000548	0.00254	CcSEcCtD
Amobarbital—Body temperature increased—Goserelin—prostate cancer	0.000542	0.00251	CcSEcCtD
Amobarbital—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000537	0.00249	CcSEcCtD
Amobarbital—Shock—Estradiol—prostate cancer	0.000535	0.00248	CcSEcCtD
Amobarbital—Mental disability—Doxorubicin—prostate cancer	0.000532	0.00246	CcSEcCtD
Amobarbital—Vomiting—Ethinyl Estradiol—prostate cancer	0.00053	0.00245	CcSEcCtD
Amobarbital—Anxiety—Mitoxantrone—prostate cancer	0.000527	0.00244	CcSEcCtD
Amobarbital—Rash—Ethinyl Estradiol—prostate cancer	0.000526	0.00243	CcSEcCtD
Amobarbital—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000525	0.00243	CcSEcCtD
Amobarbital—Headache—Ethinyl Estradiol—prostate cancer	0.000522	0.00242	CcSEcCtD
Amobarbital—Thiopental—CYP2E1—prostate cancer	0.000514	0.0937	CrCbGaD
Amobarbital—Confusional state—Mitoxantrone—prostate cancer	0.000511	0.00237	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Epirubicin—prostate cancer	0.00051	0.00236	CcSEcCtD
Amobarbital—Hypersensitivity—Goserelin—prostate cancer	0.000506	0.00234	CcSEcCtD
Amobarbital—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000501	0.00232	CcSEcCtD
Amobarbital—Shock—Mitoxantrone—prostate cancer	0.000499	0.00231	CcSEcCtD
Amobarbital—Nausea—Ethinyl Estradiol—prostate cancer	0.000495	0.00229	CcSEcCtD
Amobarbital—Bradycardia—Capecitabine—prostate cancer	0.000486	0.00225	CcSEcCtD
Amobarbital—Somnolence—Estradiol—prostate cancer	0.000484	0.00224	CcSEcCtD
Amobarbital—Hypotension—Mitoxantrone—prostate cancer	0.000474	0.00219	CcSEcCtD
Amobarbital—Dermatitis exfoliative—Doxorubicin—prostate cancer	0.000471	0.00218	CcSEcCtD
Amobarbital—Phenobarbital—CYP3A5—prostate cancer	0.000465	0.0847	CrCbGaD
Amobarbital—Constipation—Estradiol—prostate cancer	0.000465	0.00215	CcSEcCtD
Amobarbital—Loss of consciousness—Etoposide—prostate cancer	0.000454	0.0021	CcSEcCtD
Amobarbital—Dizziness—Goserelin—prostate cancer	0.000454	0.0021	CcSEcCtD
Amobarbital—Ataxia—Epirubicin—prostate cancer	0.000452	0.00209	CcSEcCtD
Amobarbital—Somnolence—Mitoxantrone—prostate cancer	0.000451	0.00209	CcSEcCtD
Amobarbital—Phenobarbital—CYP2A6—prostate cancer	0.00045	0.082	CrCbGaD
Amobarbital—Dizziness—Conjugated Estrogens—prostate cancer	0.000449	0.00208	CcSEcCtD
Amobarbital—Feeling abnormal—Estradiol—prostate cancer	0.000448	0.00208	CcSEcCtD
Amobarbital—Vomiting—Goserelin—prostate cancer	0.000436	0.00202	CcSEcCtD
Amobarbital—Constipation—Mitoxantrone—prostate cancer	0.000433	0.00201	CcSEcCtD
Amobarbital—Bradycardia—Prednisone—prostate cancer	0.000433	0.002	CcSEcCtD
Amobarbital—Rash—Goserelin—prostate cancer	0.000433	0.002	CcSEcCtD
Amobarbital—Dermatitis—Goserelin—prostate cancer	0.000432	0.002	CcSEcCtD
Amobarbital—Vomiting—Conjugated Estrogens—prostate cancer	0.000432	0.002	CcSEcCtD
Amobarbital—Body temperature increased—Estradiol—prostate cancer	0.00043	0.00199	CcSEcCtD
Amobarbital—Headache—Goserelin—prostate cancer	0.00043	0.00199	CcSEcCtD
Amobarbital—Rash—Conjugated Estrogens—prostate cancer	0.000429	0.00198	CcSEcCtD
Amobarbital—Dermatitis—Conjugated Estrogens—prostate cancer	0.000428	0.00198	CcSEcCtD
Amobarbital—Headache—Conjugated Estrogens—prostate cancer	0.000426	0.00197	CcSEcCtD
Amobarbital—Confusional state—Etoposide—prostate cancer	0.000425	0.00197	CcSEcCtD
Amobarbital—Hallucination—Prednisone—prostate cancer	0.000423	0.00196	CcSEcCtD
Amobarbital—Pentobarbital—CYP2C19—prostate cancer	0.000423	0.077	CrCbGaD
Amobarbital—Ataxia—Doxorubicin—prostate cancer	0.000418	0.00194	CcSEcCtD
Amobarbital—Feeling abnormal—Mitoxantrone—prostate cancer	0.000418	0.00193	CcSEcCtD
Amobarbital—Nausea—Goserelin—prostate cancer	0.000408	0.00189	CcSEcCtD
Amobarbital—Nausea—Conjugated Estrogens—prostate cancer	0.000404	0.00187	CcSEcCtD
Amobarbital—Hypersensitivity—Estradiol—prostate cancer	0.000401	0.00186	CcSEcCtD
Amobarbital—Body temperature increased—Mitoxantrone—prostate cancer	0.000401	0.00185	CcSEcCtD
Amobarbital—Hypotension—Etoposide—prostate cancer	0.000394	0.00182	CcSEcCtD
Amobarbital—Syncope—Docetaxel—prostate cancer	0.000385	0.00178	CcSEcCtD
Amobarbital—Loss of consciousness—Docetaxel—prostate cancer	0.000377	0.00175	CcSEcCtD
Amobarbital—Somnolence—Etoposide—prostate cancer	0.000375	0.00173	CcSEcCtD
Amobarbital—Hypersensitivity—Mitoxantrone—prostate cancer	0.000373	0.00173	CcSEcCtD
Amobarbital—Syncope—Capecitabine—prostate cancer	0.000373	0.00173	CcSEcCtD
Amobarbital—Loss of consciousness—Capecitabine—prostate cancer	0.000365	0.00169	CcSEcCtD
Amobarbital—Constipation—Etoposide—prostate cancer	0.000361	0.00167	CcSEcCtD
Amobarbital—Dizziness—Estradiol—prostate cancer	0.00036	0.00167	CcSEcCtD
Amobarbital—Confusional state—Docetaxel—prostate cancer	0.000353	0.00164	CcSEcCtD
Amobarbital—Anxiety—Capecitabine—prostate cancer	0.000353	0.00163	CcSEcCtD
Amobarbital—Feeling abnormal—Etoposide—prostate cancer	0.000347	0.00161	CcSEcCtD
Amobarbital—Vomiting—Estradiol—prostate cancer	0.000346	0.0016	CcSEcCtD
Amobarbital—Shock—Docetaxel—prostate cancer	0.000345	0.0016	CcSEcCtD
Amobarbital—Rash—Estradiol—prostate cancer	0.000343	0.00159	CcSEcCtD
Amobarbital—Dermatitis—Estradiol—prostate cancer	0.000343	0.00159	CcSEcCtD
Amobarbital—Confusional state—Capecitabine—prostate cancer	0.000342	0.00158	CcSEcCtD
Amobarbital—Headache—Estradiol—prostate cancer	0.000341	0.00158	CcSEcCtD
Amobarbital—Agitation—Prednisone—prostate cancer	0.00034	0.00157	CcSEcCtD
Amobarbital—Bradycardia—Epirubicin—prostate cancer	0.000339	0.00157	CcSEcCtD
Amobarbital—Angioedema—Prednisone—prostate cancer	0.000338	0.00157	CcSEcCtD
Amobarbital—Shock—Capecitabine—prostate cancer	0.000334	0.00154	CcSEcCtD
Amobarbital—Body temperature increased—Etoposide—prostate cancer	0.000333	0.00154	CcSEcCtD
Amobarbital—Syncope—Prednisone—prostate cancer	0.000332	0.00154	CcSEcCtD
Amobarbital—Hypotension—Docetaxel—prostate cancer	0.000327	0.00152	CcSEcCtD
Amobarbital—Loss of consciousness—Prednisone—prostate cancer	0.000325	0.00151	CcSEcCtD
Amobarbital—Thiopental—CYP3A4—prostate cancer	0.000324	0.059	CrCbGaD
Amobarbital—Nausea—Estradiol—prostate cancer	0.000323	0.0015	CcSEcCtD
Amobarbital—Vomiting—Mitoxantrone—prostate cancer	0.000322	0.00149	CcSEcCtD
Amobarbital—Phenobarbital—CYP2E1—prostate cancer	0.00032	0.0582	CrCbGaD
Amobarbital—Rash—Mitoxantrone—prostate cancer	0.00032	0.00148	CcSEcCtD
Amobarbital—Dermatitis—Mitoxantrone—prostate cancer	0.000319	0.00148	CcSEcCtD
Amobarbital—Headache—Mitoxantrone—prostate cancer	0.000318	0.00147	CcSEcCtD
Amobarbital—Hypotension—Capecitabine—prostate cancer	0.000317	0.00147	CcSEcCtD
Amobarbital—Phenobarbital—CYP2C19—prostate cancer	0.000317	0.0577	CrCbGaD
Amobarbital—Phenobarbital—CYP1A1—prostate cancer	0.000315	0.0575	CrCbGaD
Amobarbital—Anxiety—Prednisone—prostate cancer	0.000314	0.00145	CcSEcCtD
Amobarbital—Bradycardia—Doxorubicin—prostate cancer	0.000313	0.00145	CcSEcCtD
Amobarbital—Somnolence—Docetaxel—prostate cancer	0.000311	0.00144	CcSEcCtD
Amobarbital—Hypersensitivity—Etoposide—prostate cancer	0.000311	0.00144	CcSEcCtD
Amobarbital—Nausea—Mitoxantrone—prostate cancer	0.000301	0.00139	CcSEcCtD
Amobarbital—Constipation—Docetaxel—prostate cancer	0.0003	0.00139	CcSEcCtD
Amobarbital—Shock—Prednisone—prostate cancer	0.000297	0.00138	CcSEcCtD
Amobarbital—Constipation—Capecitabine—prostate cancer	0.00029	0.00134	CcSEcCtD
Amobarbital—Feeling abnormal—Docetaxel—prostate cancer	0.000289	0.00134	CcSEcCtD
Amobarbital—Tension—Epirubicin—prostate cancer	0.000284	0.00132	CcSEcCtD
Amobarbital—Nervousness—Epirubicin—prostate cancer	0.000281	0.0013	CcSEcCtD
Amobarbital—Feeling abnormal—Capecitabine—prostate cancer	0.00028	0.00129	CcSEcCtD
Amobarbital—Dizziness—Etoposide—prostate cancer	0.000279	0.00129	CcSEcCtD
Amobarbital—Body temperature increased—Docetaxel—prostate cancer	0.000277	0.00128	CcSEcCtD
Amobarbital—Pentobarbital—CYP3A4—prostate cancer	0.000269	0.049	CrCbGaD
Amobarbital—Body temperature increased—Capecitabine—prostate cancer	0.000268	0.00124	CcSEcCtD
Amobarbital—Vomiting—Etoposide—prostate cancer	0.000268	0.00124	CcSEcCtD
Amobarbital—Agitation—Epirubicin—prostate cancer	0.000266	0.00123	CcSEcCtD
Amobarbital—Rash—Etoposide—prostate cancer	0.000266	0.00123	CcSEcCtD
Amobarbital—Dermatitis—Etoposide—prostate cancer	0.000266	0.00123	CcSEcCtD
Amobarbital—Headache—Etoposide—prostate cancer	0.000264	0.00122	CcSEcCtD
Amobarbital—Tension—Doxorubicin—prostate cancer	0.000263	0.00122	CcSEcCtD
Amobarbital—Nervousness—Doxorubicin—prostate cancer	0.00026	0.0012	CcSEcCtD
Amobarbital—Syncope—Epirubicin—prostate cancer	0.00026	0.0012	CcSEcCtD
Amobarbital—Constipation—Prednisone—prostate cancer	0.000258	0.0012	CcSEcCtD
Amobarbital—Hypersensitivity—Docetaxel—prostate cancer	0.000258	0.00119	CcSEcCtD
Amobarbital—Loss of consciousness—Epirubicin—prostate cancer	0.000255	0.00118	CcSEcCtD
Amobarbital—Nausea—Etoposide—prostate cancer	0.00025	0.00116	CcSEcCtD
Amobarbital—Hypersensitivity—Capecitabine—prostate cancer	0.00025	0.00116	CcSEcCtD
Amobarbital—Feeling abnormal—Prednisone—prostate cancer	0.000249	0.00115	CcSEcCtD
Amobarbital—Agitation—Doxorubicin—prostate cancer	0.000246	0.00114	CcSEcCtD
Amobarbital—Anxiety—Epirubicin—prostate cancer	0.000246	0.00114	CcSEcCtD
Amobarbital—Syncope—Doxorubicin—prostate cancer	0.00024	0.00111	CcSEcCtD
Amobarbital—Body temperature increased—Prednisone—prostate cancer	0.000239	0.00111	CcSEcCtD
Amobarbital—Confusional state—Epirubicin—prostate cancer	0.000238	0.0011	CcSEcCtD
Amobarbital—Loss of consciousness—Doxorubicin—prostate cancer	0.000235	0.00109	CcSEcCtD
Amobarbital—Shock—Epirubicin—prostate cancer	0.000233	0.00108	CcSEcCtD
Amobarbital—Dizziness—Docetaxel—prostate cancer	0.000232	0.00107	CcSEcCtD
Amobarbital—Anxiety—Doxorubicin—prostate cancer	0.000227	0.00105	CcSEcCtD
Amobarbital—Dizziness—Capecitabine—prostate cancer	0.000224	0.00104	CcSEcCtD
Amobarbital—Vomiting—Docetaxel—prostate cancer	0.000223	0.00103	CcSEcCtD
Amobarbital—Hypersensitivity—Prednisone—prostate cancer	0.000223	0.00103	CcSEcCtD
Amobarbital—Rash—Docetaxel—prostate cancer	0.000221	0.00102	CcSEcCtD
Amobarbital—Hypotension—Epirubicin—prostate cancer	0.000221	0.00102	CcSEcCtD
Amobarbital—Dermatitis—Docetaxel—prostate cancer	0.000221	0.00102	CcSEcCtD
Amobarbital—Confusional state—Doxorubicin—prostate cancer	0.00022	0.00102	CcSEcCtD
Amobarbital—Headache—Docetaxel—prostate cancer	0.000219	0.00102	CcSEcCtD
Amobarbital—Vomiting—Capecitabine—prostate cancer	0.000216	0.000998	CcSEcCtD
Amobarbital—Shock—Doxorubicin—prostate cancer	0.000215	0.000996	CcSEcCtD
Amobarbital—Rash—Capecitabine—prostate cancer	0.000214	0.00099	CcSEcCtD
Amobarbital—Dermatitis—Capecitabine—prostate cancer	0.000214	0.000989	CcSEcCtD
Amobarbital—Headache—Capecitabine—prostate cancer	0.000213	0.000984	CcSEcCtD
Amobarbital—Somnolence—Epirubicin—prostate cancer	0.00021	0.000973	CcSEcCtD
Amobarbital—Nausea—Docetaxel—prostate cancer	0.000208	0.000963	CcSEcCtD
Amobarbital—Hypotension—Doxorubicin—prostate cancer	0.000204	0.000946	CcSEcCtD
Amobarbital—Constipation—Epirubicin—prostate cancer	0.000202	0.000935	CcSEcCtD
Amobarbital—Nausea—Capecitabine—prostate cancer	0.000201	0.000933	CcSEcCtD
Amobarbital—Phenobarbital—CYP3A4—prostate cancer	0.000201	0.0367	CrCbGaD
Amobarbital—Dizziness—Prednisone—prostate cancer	0.0002	0.000925	CcSEcCtD
Amobarbital—Feeling abnormal—Epirubicin—prostate cancer	0.000195	0.000901	CcSEcCtD
Amobarbital—Somnolence—Doxorubicin—prostate cancer	0.000194	0.0009	CcSEcCtD
Amobarbital—Vomiting—Prednisone—prostate cancer	0.000192	0.000889	CcSEcCtD
Amobarbital—Rash—Prednisone—prostate cancer	0.000191	0.000882	CcSEcCtD
Amobarbital—Dermatitis—Prednisone—prostate cancer	0.00019	0.000881	CcSEcCtD
Amobarbital—Headache—Prednisone—prostate cancer	0.000189	0.000876	CcSEcCtD
Amobarbital—Constipation—Doxorubicin—prostate cancer	0.000187	0.000866	CcSEcCtD
Amobarbital—Body temperature increased—Epirubicin—prostate cancer	0.000187	0.000865	CcSEcCtD
Amobarbital—Feeling abnormal—Doxorubicin—prostate cancer	0.00018	0.000834	CcSEcCtD
Amobarbital—Nausea—Prednisone—prostate cancer	0.000179	0.000831	CcSEcCtD
Amobarbital—Hypersensitivity—Epirubicin—prostate cancer	0.000174	0.000806	CcSEcCtD
Amobarbital—Body temperature increased—Doxorubicin—prostate cancer	0.000173	0.0008	CcSEcCtD
Amobarbital—Hypersensitivity—Doxorubicin—prostate cancer	0.000161	0.000746	CcSEcCtD
Amobarbital—Dizziness—Epirubicin—prostate cancer	0.000156	0.000723	CcSEcCtD
Amobarbital—Vomiting—Epirubicin—prostate cancer	0.00015	0.000696	CcSEcCtD
Amobarbital—Rash—Epirubicin—prostate cancer	0.000149	0.00069	CcSEcCtD
Amobarbital—Dermatitis—Epirubicin—prostate cancer	0.000149	0.000689	CcSEcCtD
Amobarbital—Headache—Epirubicin—prostate cancer	0.000148	0.000685	CcSEcCtD
Amobarbital—Dizziness—Doxorubicin—prostate cancer	0.000145	0.000669	CcSEcCtD
Amobarbital—Nausea—Epirubicin—prostate cancer	0.00014	0.00065	CcSEcCtD
Amobarbital—Vomiting—Doxorubicin—prostate cancer	0.000139	0.000644	CcSEcCtD
Amobarbital—Rash—Doxorubicin—prostate cancer	0.000138	0.000638	CcSEcCtD
Amobarbital—Dermatitis—Doxorubicin—prostate cancer	0.000138	0.000638	CcSEcCtD
Amobarbital—Headache—Doxorubicin—prostate cancer	0.000137	0.000634	CcSEcCtD
Amobarbital—Nausea—Doxorubicin—prostate cancer	0.00013	0.000601	CcSEcCtD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.000107	0.00073	CbGpPWpGaD
Amobarbital—GRIK2—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000106	0.000727	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000105	0.000722	CbGpPWpGaD
Amobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.000105	0.000717	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP2E1—prostate cancer	0.000104	0.000716	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—RXRA—prostate cancer	0.000102	0.000702	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL10—prostate cancer	0.000102	0.000696	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000101	0.000696	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP3A4—prostate cancer	0.000101	0.00069	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—ACHE—prostate cancer	0.0001	0.000686	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—ABCG5—prostate cancer	9.96e-05	0.000683	CbGpPWpGaD
Amobarbital—CYP2A6—Fluoropyrimidine Activity—TP53—prostate cancer	9.95e-05	0.000682	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP1B1—prostate cancer	9.9e-05	0.000679	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	9.85e-05	0.000675	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—ABCG5—prostate cancer	9.83e-05	0.000674	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—TGFBR2—prostate cancer	9.82e-05	0.000673	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTP1—prostate cancer	9.82e-05	0.000673	CbGpPWpGaD
Amobarbital—GABRA1—Orphan transporters—CREBBP—prostate cancer	9.67e-05	0.000663	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—COMT—prostate cancer	9.66e-05	0.000662	CbGpPWpGaD
Amobarbital—CHRNA7—Transmission across Chemical Synapses—MDM2—prostate cancer	9.65e-05	0.000661	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	9.6e-05	0.000658	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	9.6e-05	0.000658	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GGT1—prostate cancer	9.59e-05	0.000657	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—PRKACB—prostate cancer	9.58e-05	0.000656	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—COMT—prostate cancer	9.54e-05	0.000654	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A3—prostate cancer	9.47e-05	0.000649	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—NCOA1—prostate cancer	9.45e-05	0.000647	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—CASP3—prostate cancer	9.44e-05	0.000647	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—EP300—prostate cancer	9.43e-05	0.000647	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—NR3C1—prostate cancer	9.4e-05	0.000644	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP19A1—prostate cancer	9.31e-05	0.000638	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A3—prostate cancer	9.3e-05	0.000637	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A3—prostate cancer	9.14e-05	0.000626	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—COMT—prostate cancer	9.1e-05	0.000624	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—CTNNB1—prostate cancer	9.1e-05	0.000623	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—GSTM1—prostate cancer	9.02e-05	0.000619	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—RXRA—prostate cancer	8.98e-05	0.000616	CbGpPWpGaD
Amobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	8.97e-05	0.000615	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—prostate cancer	8.97e-05	0.000615	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—prostate cancer	8.94e-05	0.000612	CbGpPWpGaD
Amobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	8.86e-05	0.000607	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	8.8e-05	0.000603	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—ABCG5—prostate cancer	8.74e-05	0.000599	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC22A1—prostate cancer	8.69e-05	0.000595	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—COMT—prostate cancer	8.65e-05	0.000593	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTP1—prostate cancer	8.61e-05	0.00059	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—prostate cancer	8.58e-05	0.000588	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—ABCG5—prostate cancer	8.58e-05	0.000588	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	8.56e-05	0.000587	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—COMT—prostate cancer	8.47e-05	0.000581	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—ABCG5—prostate cancer	8.43e-05	0.000578	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—GNG5—prostate cancer	8.37e-05	0.000573	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—COMT—prostate cancer	8.32e-05	0.00057	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	8.27e-05	0.000567	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—GNG5—prostate cancer	8.26e-05	0.000566	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—SRC—prostate cancer	8.22e-05	0.000563	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—COMT—prostate cancer	8.18e-05	0.000561	CbGpPWpGaD
Amobarbital—GRIK2—Neuronal System—MDM2—prostate cancer	8.12e-05	0.000557	CbGpPWpGaD
Amobarbital—GRIA2—Transmission across Chemical Synapses—MDM2—prostate cancer	8.11e-05	0.000556	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—STAT3—prostate cancer	7.93e-05	0.000543	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—GSTM1—prostate cancer	7.92e-05	0.000543	CbGpPWpGaD
Amobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	7.87e-05	0.000539	CbGpPWpGaD
Amobarbital—CHRNA4—Transmission across Chemical Synapses—MDM2—prostate cancer	7.86e-05	0.000539	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	7.79e-05	0.000534	CbGpPWpGaD
Amobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	7.73e-05	0.00053	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC22A1—prostate cancer	7.72e-05	0.000529	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—EP300—prostate cancer	7.69e-05	0.000527	CbGpPWpGaD
Amobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	7.59e-05	0.000521	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC22A1—prostate cancer	7.58e-05	0.000519	CbGpPWpGaD
Amobarbital—CYP2A6—Biological oxidations—CYP1A1—prostate cancer	7.5e-05	0.000514	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC22A1—prostate cancer	7.45e-05	0.00051	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HAO1—prostate cancer	7.41e-05	0.000508	CbGpPWpGaD
Amobarbital—CHRNA7—Neuronal System—MDM2—prostate cancer	7.39e-05	0.000507	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—GNG5—prostate cancer	7.34e-05	0.000503	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—prostate cancer	7.28e-05	0.000499	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—GNG5—prostate cancer	7.21e-05	0.000494	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—ABCG5—prostate cancer	7.19e-05	0.000493	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.13e-05	0.000489	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—GNG5—prostate cancer	7.08e-05	0.000486	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—PRKACB—prostate cancer	7.04e-05	0.000483	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	6.99e-05	0.000479	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—COMT—prostate cancer	6.97e-05	0.000478	CbGpPWpGaD
Amobarbital—GABRA6—Transmission across Chemical Synapses—MDM2—prostate cancer	6.74e-05	0.000462	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—NCOA2—prostate cancer	6.73e-05	0.000461	CbGpPWpGaD
Amobarbital—GABRA4—Transmission across Chemical Synapses—MDM2—prostate cancer	6.66e-05	0.000456	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—NCOA2—prostate cancer	6.64e-05	0.000455	CbGpPWpGaD
Amobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	6.48e-05	0.000444	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.42e-05	0.00044	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	6.35e-05	0.000435	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—prostate cancer	6.34e-05	0.000434	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.26e-05	0.000429	CbGpPWpGaD
Amobarbital—GRIA2—Neuronal System—MDM2—prostate cancer	6.21e-05	0.000426	CbGpPWpGaD
Amobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—prostate cancer	6.18e-05	0.000424	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.14e-05	0.000421	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—PRKACB—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GRHL1—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TST—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CSAD—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PSAT1—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CBR1—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ADI1—prostate cancer	6.04e-05	0.000414	CbGpPWpGaD
Amobarbital—CHRNA4—Neuronal System—MDM2—prostate cancer	6.02e-05	0.000413	CbGpPWpGaD
Amobarbital—GABRA5—Transmission across Chemical Synapses—MDM2—prostate cancer	5.92e-05	0.000405	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.9e-05	0.000404	CbGpPWpGaD
Amobarbital—GABRA3—Transmission across Chemical Synapses—MDM2—prostate cancer	5.81e-05	0.000398	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.79e-05	0.000397	CbGpPWpGaD
Amobarbital—GABRA2—Transmission across Chemical Synapses—MDM2—prostate cancer	5.71e-05	0.000391	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—NCOA2—prostate cancer	5.69e-05	0.00039	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.67e-05	0.000389	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.63e-05	0.000386	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CKMT2—prostate cancer	5.61e-05	0.000385	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—UGT2B17—prostate cancer	5.61e-05	0.000385	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—UGT2B15—prostate cancer	5.61e-05	0.000385	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GRHPR—prostate cancer	5.61e-05	0.000385	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—NCOA1—prostate cancer	5.6e-05	0.000384	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	5.55e-05	0.000381	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.53e-05	0.000379	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—prostate cancer	5.43e-05	0.000372	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—RXRA—prostate cancer	5.39e-05	0.00037	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—RXRA—prostate cancer	5.32e-05	0.000365	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	5.31e-05	0.000364	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PGAM2—prostate cancer	5.28e-05	0.000362	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—RFK—prostate cancer	5.28e-05	0.000362	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AOX1—prostate cancer	5.28e-05	0.000362	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SULT2B1—prostate cancer	5.28e-05	0.000362	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MBTPS1—prostate cancer	5.28e-05	0.000362	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NAGLU—prostate cancer	5.28e-05	0.000362	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTM3—prostate cancer	5.28e-05	0.000362	CbGpPWpGaD
Amobarbital—GABRA6—Neuronal System—MDM2—prostate cancer	5.17e-05	0.000354	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	5.15e-05	0.000353	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	5.12e-05	0.000351	CbGpPWpGaD
Amobarbital—GRIA2—BDNF signaling pathway—AKT1—prostate cancer	5.11e-05	0.00035	CbGpPWpGaD
Amobarbital—GABRA4—Neuronal System—MDM2—prostate cancer	5.1e-05	0.00035	CbGpPWpGaD
Amobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—prostate cancer	5.04e-05	0.000345	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—DEGS1—prostate cancer	5e-05	0.000343	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP3A43—prostate cancer	5e-05	0.000343	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AMACR—prostate cancer	5e-05	0.000343	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SRD5A2—prostate cancer	5e-05	0.000343	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NAT1—prostate cancer	5e-05	0.000343	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.97e-05	0.000341	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.88e-05	0.000335	CbGpPWpGaD
Amobarbital—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	4.87e-05	0.000334	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	4.86e-05	0.000333	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.8e-05	0.000329	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HSD17B1—prostate cancer	4.77e-05	0.000327	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	4.76e-05	0.000326	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—RXRA—prostate cancer	4.73e-05	0.000324	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—RXRA—prostate cancer	4.64e-05	0.000318	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	4.63e-05	0.000318	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—RXRA—prostate cancer	4.56e-05	0.000313	CbGpPWpGaD
Amobarbital—GABRA5—Neuronal System—MDM2—prostate cancer	4.53e-05	0.000311	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	4.51e-05	0.000309	CbGpPWpGaD
Amobarbital—GABRA3—Neuronal System—MDM2—prostate cancer	4.45e-05	0.000305	CbGpPWpGaD
Amobarbital—GABRA2—Neuronal System—MDM2—prostate cancer	4.37e-05	0.0003	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—B4GALT4—prostate cancer	4.25e-05	0.000292	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HPGD—prostate cancer	4.25e-05	0.000292	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—PPARA—prostate cancer	4.12e-05	0.000282	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	4.09e-05	0.00028	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—PPARA—prostate cancer	4.07e-05	0.000279	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TNFRSF21—prostate cancer	4e-05	0.000274	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	3.89e-05	0.000267	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP7B1—prostate cancer	3.89e-05	0.000267	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MTAP—prostate cancer	3.89e-05	0.000267	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SULT1E1—prostate cancer	3.79e-05	0.00026	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SRD5A1—prostate cancer	3.79e-05	0.00026	CbGpPWpGaD
Amobarbital—GABRA1—Neuronal System—MDM2—prostate cancer	3.73e-05	0.000256	CbGpPWpGaD
Amobarbital—CYP2A6—NRF2 pathway—TGFB1—prostate cancer	3.68e-05	0.000252	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ACSL4—prostate cancer	3.62e-05	0.000248	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HSD17B3—prostate cancer	3.62e-05	0.000248	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—PPARA—prostate cancer	3.61e-05	0.000248	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—PPARA—prostate cancer	3.55e-05	0.000243	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—PPARA—prostate cancer	3.49e-05	0.000239	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ARG2—prostate cancer	3.47e-05	0.000238	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PHGDH—prostate cancer	3.47e-05	0.000238	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—UMPS—prostate cancer	3.47e-05	0.000238	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—LDHB—prostate cancer	3.4e-05	0.000233	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP3A5—prostate cancer	3.34e-05	0.000229	CbGpPWpGaD
Amobarbital—GABRA6—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.27e-05	0.000224	CbGpPWpGaD
Amobarbital—GABRA4—Transmembrane transport of small molecules—CREBBP—prostate cancer	3.23e-05	0.000221	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PDHA1—prostate cancer	3.22e-05	0.000221	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TCN2—prostate cancer	3.22e-05	0.000221	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—UCP3—prostate cancer	3.22e-05	0.000221	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTA3—prostate cancer	3.22e-05	0.000221	CbGpPWpGaD
Amobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	3.12e-05	0.000214	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC22A3—prostate cancer	3.08e-05	0.000211	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HSD3B1—prostate cancer	3.08e-05	0.000211	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.97e-05	0.000204	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTA4—prostate cancer	2.95e-05	0.000202	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TBXAS1—prostate cancer	2.95e-05	0.000202	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTA2—prostate cancer	2.87e-05	0.000197	CbGpPWpGaD
Amobarbital—GABRA5—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.87e-05	0.000197	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SULT1A1—prostate cancer	2.84e-05	0.000195	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ABCG5—prostate cancer	2.84e-05	0.000195	CbGpPWpGaD
Amobarbital—GABRA3—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.82e-05	0.000193	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTA1—prostate cancer	2.77e-05	0.00019	CbGpPWpGaD
Amobarbital—GABRA2—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.77e-05	0.00019	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HSD3B2—prostate cancer	2.74e-05	0.000188	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NAT2—prostate cancer	2.74e-05	0.000188	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTO1—prostate cancer	2.74e-05	0.000188	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—LRP2—prostate cancer	2.63e-05	0.00018	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PLCB2—prostate cancer	2.63e-05	0.00018	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP2C18—prostate cancer	2.63e-05	0.00018	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—P4HB—prostate cancer	2.58e-05	0.000177	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC22A1—prostate cancer	2.51e-05	0.000172	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SULT2A1—prostate cancer	2.44e-05	0.000167	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MED12—prostate cancer	2.4e-05	0.000165	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GNG5—prostate cancer	2.38e-05	0.000163	CbGpPWpGaD
Amobarbital—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	2.36e-05	0.000162	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NCOA3—prostate cancer	2.3e-05	0.000157	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—HPGDS—prostate cancer	2.19e-05	0.00015	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP2C19—prostate cancer	2.18e-05	0.000149	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTT1—prostate cancer	2.13e-05	0.000146	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ACHE—prostate cancer	2.13e-05	0.000146	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AKR1C3—prostate cancer	2.04e-05	0.00014	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PRKACB—prostate cancer	2.03e-05	0.000139	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP17A1—prostate cancer	2.01e-05	0.000138	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NCOA2—prostate cancer	1.92e-05	0.000131	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—SLC5A5—prostate cancer	1.83e-05	0.000125	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP2E1—prostate cancer	1.79e-05	0.000122	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NQO1—prostate cancer	1.77e-05	0.000121	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TH—prostate cancer	1.74e-05	0.000119	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP3A4—prostate cancer	1.72e-05	0.000118	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP1B1—prostate cancer	1.69e-05	0.000116	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GGT1—prostate cancer	1.64e-05	0.000112	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NCOA1—prostate cancer	1.62e-05	0.000111	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP19A1—prostate cancer	1.59e-05	0.000109	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—RXRA—prostate cancer	1.54e-05	0.000105	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—COMT—prostate cancer	1.48e-05	0.000101	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTP1—prostate cancer	1.47e-05	0.000101	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ITPR1—prostate cancer	1.45e-05	9.94e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—TYMS—prostate cancer	1.37e-05	9.39e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—GSTM1—prostate cancer	1.35e-05	9.28e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—LPL—prostate cancer	1.33e-05	9.11e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CYP1A1—prostate cancer	1.28e-05	8.8e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—ERCC2—prostate cancer	1.27e-05	8.72e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—MTHFR—prostate cancer	1.2e-05	8.2e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PPARA—prostate cancer	1.17e-05	8.05e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CAV1—prostate cancer	1.1e-05	7.56e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CG—prostate cancer	1.01e-05	6.89e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—INS—prostate cancer	9.52e-06	6.52e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—CREBBP—prostate cancer	9.32e-06	6.39e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CD—prostate cancer	8.84e-06	6.06e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—NOS3—prostate cancer	8.34e-06	5.72e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CB—prostate cancer	7.7e-06	5.28e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTGS2—prostate cancer	7.63e-06	5.23e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PTEN—prostate cancer	6.66e-06	4.56e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—EP300—prostate cancer	6.35e-06	4.35e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—PIK3CA—prostate cancer	4.7e-06	3.22e-05	CbGpPWpGaD
Amobarbital—CYP2A6—Metabolism—AKT1—prostate cancer	3.84e-06	2.63e-05	CbGpPWpGaD
